Skip to main content
Clinical Trials/CTRI/2024/03/063773
CTRI/2024/03/063773
Not yet recruiting
Phase 2

To Evaluate the analgesic efficacy of the anterior femoral cutaneous nerve block (AFCNB) combined with the adductor canal block (ACB) in patients undergoing unilateral total knee replacement (TKR) : A randomized controlled trial - Nil

Josemine Davis0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Josemine Davis
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Josemine Davis

Eligibility Criteria

Inclusion Criteria

  • 1\.Adults aged 18 years and older undergoing unilateral TKR
  • 2\.ASA classification I\-III.
  • 3\.Patients capable of providing informed consent or with consent provided by a legal guardian.
  • 4\.Patients who can comprehend and cooperate with study procedures and pain assessment tools.

Exclusion Criteria

  • 1\.Patients with contraindications or allergies to local anaesthetics used in nerve block procedures.
  • 2\.Patients scheduled for emergency orthopaedic procedures.
  • 3\.Patients with chronic opioid use or opioid tolerance.
  • 4\.Patients with pre\-existing neurological disorders that may affect pain perception.
  • 5\.Patients with coagulopathies or those on anticoagulant therapy that cannot be temporarily stopped.
  • 6\.Known allergies to components of the nerve block procedures.
  • 7\.Patients with active infections or open wounds at the site of the nerve block.
  • 8\.Pregnant or lactating women.
  • 9\.Patients currently enrolled in other clinical trials or studies involving pain management techniques.

Outcomes

Primary Outcomes

Not specified

Similar Trials